Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types

Journal of Clinical Microbiology

Volumn 44, Issue 6, 2006, Pages 2025-2031

  Gheit, Tarik ^a   Landi, Stefano ^b   Gemignani, Federica ^b   Snijders, Peter J F ^c   Vaccarella, Salvatore ^a   Franceschi, Silvia ^a   Canzian, Federico ^d   Tommasino, Massimo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF PISA   (Italy)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANALYTIC METHOD; ARTICLE; DNA MICROARRAY; DNA MICROARRAY PRIMER EXTENSION; EPIDEMIOLOGY; FEMALE; GENE AMPLIFICATION; GP5 PLUS GP6 PLUS POLYMERASE CHAIN REACTION; HIGH RISK MUCOSAL HUMAN PAPILLOMA VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; MAJOR CLINICAL STUDY; MUCOSA; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE LINE BLOT ASSAY; SLOT BLOT HYBRIDIZATION; VALIDATION PROCESS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

DNA PRIMERS; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MUCOUS MEMBRANE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE;

EID: 33745157895     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02305-05     Document Type: Article

References (32)

1. Altman, D. G. 1991. Practical statistics for medical research. Chapman & Hall, Ltd., London, England.
2. 1a. Auffray, C., C. Mundy, and A. Metspalu. 2000. DNA arrays: methods and applications: report on HUGO Meeting, Tartu, Estonia, 23-26 May, 1999. Eur. J. Hum. Genet. 8:236-238.
3. Clavel, C., M. Masure, J. P. Bory, I. Putaud, C. Mangeonjean, M. Lorenzato, P. Nazeyrollas, R. Gabriel, C. Quereux, and P. Birembaut. 2001. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84:1616-1623.
4. Coutlee, F., P. Gravitt, J. Kornegay, C. Hankins, H. Richardson, N. Lapointe, H. Voyer, and E. Franco. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 40:902-907.
5. Cox, J. T. 1996. Clinical role of HPV testing. Obstet. Gynecol. Clin. N. Am. 23:811-851.
6. Cuzick, J., E. Beverley, L. Ho, G. Terry, H. Sapper, I. Mielzynska, A. Lorincz, W. K. Chan, T. Krausz, and P. Soutter. 1999. HPV testing in primary screening of older women. Br. J. Cancer 81:554-558.
7. Ferlay, J., F. Bray, P. Pisani, and D. M. Parkin. 2001. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon, France.
8. Fujinaga, Y., M. Shimada, K. Okazawa, M. Fukushima, I. Kato, and K. Fujinaga. 1991. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J. Gen. Virol. 72(Pt 5):1039-1044.
9. Gemignani, F., S. Landi, A. Chabrier, A. Smet, I. Zehbe, F. Canzian, and M. Tommasino. 2004. Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16. J. Virol. Methods 119:95-102.
10. Guo, Z., R. A. Guilfoyle, A. J. Thiel, R. Wang, and L. M. Smith. 1994. Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res. 22:5456-5465.
11. IARC Working Group, on the Evaluation of Cancer Prevention Strategies. 2005. Cervix cancer screening, vol. 10. IARC Press, Lyon, France.
12. Karlsen, F., M. Kalantari, A. Jenkins, E. Pettersen, G. Kristensen, R. Holm, B. Johansson, and B. Hagmar. 1996. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 34:2095-2100.
13. Kaufman, R. H., and E. Adam. 1999. Is human papillomavirus testing of value in clinical practice? Am. J. Obstet. Gynecol. 180:1049-1053.
14. Kurg, A., N. Tonisson, I. Georgiou, J. Shumaker, J. Tollett, and A. Metspalu. 2000. Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet. Test. 4:1-7.
15. Manos, M. M., W. K. Kinney, L. B. Hurley, M. E. Sherman, J. Shieh-Ngai, R. J. Kurman, J. E. Ransley, B. J. Fetterman, J. S. Hartinger, K. M. McIntosh, G. F. Pawlick, and R. A. Hiatt. 1999. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:1605-1610.
16. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
17. Perrons, C., B. Kleter, R. Jelley, H. Jalal, W. Quint, and R. Tedder. 2002. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J. Med. Virol. 67:246-252.
18. Qu, W., G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho, R. S. Klein, and R. D. Burk. 1997. PCR detection of human papillomavirus: comparison between MY09/ MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1304-1310.
19. Resnick, R. M., M. T. Cornelissen, D. K. Wright, G. H. Eichinger, H. S. Fox, J. ter Schegget, and M. M. Manos. 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82:1477-1484.
20. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
21. Sasagawa, T., Y. Minemoto, W. Basha, H. Yamazaki, M. Nakamura, H. Yoshimoto, J. Sakaike, and M. Inoue. 2000. A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV). Virus Res. 67:127-139.
22. Sasieni, P. D., J. Cuzick, E. Lynch-Farmery, et al. 1996. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br. J. Cancer 73:1001-1005.
23. Schiffman, M., R. Herrero, A. Hildesheim, M. E. Sherman, M. Bratti, S. Wacholder, M. Alfaro, M. Hutchinson, J. Morales, M. D. Greenberg, and A. T. Lorincz. 2000. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283:87-93.
24. Shumaker, J. M., A. Metspalu, and C. T. Caskey. 1996. Mutation detection by solid phase primer extension. Hum. Mutat. 7:346-354.
25. Smits, H. L., L. J. Bollen, A. H. S. P. Tjong, J. Vonk, J. Van Der Velden, F. J. Ten Kate, J. A. Kaan, B. W. Mol, and J. Ter Schegget. 1995. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J. Clin. Microbiol. 33:2631-2636.
26. Snijders, P. J., A. J. van den Brule, H. F. Schrijnemakers, G. Snow, C. J. Meijer, and J. M. Walboomers. 1990. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol. 71(Pt 1):173-181.
27. Tieben, L. M., J. ter Schegget, R. P. Minnaar, J. N. Bouwes Bavinck, R. J. Berkhout, B. J. Vermeer, M. F. Jebbink, and H. L. Smits. 1993. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J. Virol. Methods 42:265-279.
28. van den Brule, A. J., R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. Meijer, and P. J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
29. van den Brule, A. J., P. J. Snijders, R. L. Gordijn, O. P. Bleker, C. J. Meijer, and J. M. Walboomers. 1990. General primer-mediated polymerase chain reaction permits the detection of scquenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int. J. Cancer 45:644-649.
30. Vizcaino, A. P., V. Moreno, F. X. Bosch, N. Munoz, X. M. Barros-Dios, J. Borras, and D. M. Parkin. 2000. International trends in incidence of cervical cancer. II. Squamous-cell carcinoma. Int. J. Cancer 86:429-435.
31. Yoshikawa, H., T. Kawana, K. Kitagawa, M. Mizuno, H. Yoshikura, and A. Iwamoto. 1991. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn. J. Cancer Res. 82:524-531.
32. Zehbe, I., E. Wilander, H. Delius, and M. Tommasino. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.